ID   AMPD3_HUMAN             Reviewed;         767 AA.
AC   Q01432; A0AUX0; B7Z2S2; B7Z763; B7Z877;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   15-MAR-2017, entry version 162.
DE   RecName: Full=AMP deaminase 3;
DE            EC=3.5.4.6;
DE   AltName: Full=AMP deaminase isoform E;
DE   AltName: Full=Erythrocyte AMP deaminase;
GN   Name=AMPD3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1B).
RX   PubMed=1420359; DOI=10.1016/0167-4781(92)90153-Q;
RA   Yamada Y., Goto H., Ogasawara N.;
RT   "Cloning and nucleotide sequence of the cDNA encoding human
RT   erythrocyte-specific AMP deaminase.";
RL   Biochim. Biophys. Acta 1171:125-128(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1A; 1B AND 1C).
RC   TISSUE=Keratinocyte;
RX   PubMed=1400401;
RA   Mahnke-Zizelman D.K., Sabina R.L.;
RT   "Cloning of human AMP deaminase isoform E cDNAs. Evidence for a third
RT   AMPD gene exhibiting alternatively spliced 5'-exons.";
RL   J. Biol. Chem. 267:20866-20877(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1B; 2 AND 3), AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=8611627; DOI=10.1016/0167-4781(95)00231-6;
RA   Mahnke-Zizelman D.K., Eddy R., Shows T.B., Sabina R.L.;
RT   "Characterization of the human AMPD3 gene reveals that 5' exon useage
RT   is subject to transcriptional control by three tandem promoters and
RT   alternative splicing.";
RL   Biochim. Biophys. Acta 1306:75-92(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1B), AND VARIANT AMPDDE
RP   CYS-573.
RX   PubMed=8004104; DOI=10.1093/hmg/3.2.331;
RA   Yamada Y., Goto H., Ogasawara N.;
RT   "A point mutation responsible for human erythrocyte AMP deaminase
RT   deficiency.";
RL   Hum. Mol. Genet. 3:331-334(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1B; 2; 3 AND 4).
RC   TISSUE=Brain, Synovium, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-107, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   VARIANTS AMPDDE LYS-310; VAL-320; THR-324; CYS-331; CYS-402; ARG-450
RP   AND LEU-585.
RX   PubMed=7881427; DOI=10.1093/hmg/3.12.2243;
RA   Yamada Y., Goto H., Murase T., Ogasawara N.;
RT   "Molecular basis for human erythrocyte AMP deaminase deficiency:
RT   screening for the major point mutation and identification of other
RT   mutations.";
RL   Hum. Mol. Genet. 3:2243-2245(1994).
RN   [12]
RP   VARIANT AMPDDE LEU-311.
RX   PubMed=9598089;
RA   Yamada Y., Makarewicz W., Goto H., Nomura N., Kitoh H., Ogasawara N.;
RT   "Gene mutations responsible for human erythrocyte AMP deaminase
RT   deficiency in Poles.";
RL   Adv. Exp. Med. Biol. 431:347-350(1998).
RN   [13]
RP   VARIANTS AMPDDE ARG-450 AND PRO-712.
RX   PubMed=11139257;
RX   DOI=10.1002/1098-1004(2001)17:1<78::AID-HUMU21>3.3.CO;2-2;
RA   Yamada Y., Goto H., Wakamatsu N., Ogasawara N.;
RT   "A rare case of complete human erythrocyte AMP deaminase deficiency
RT   due to two novel missense mutations in AMPD3.";
RL   Hum. Mutat. 17:78-78(2001).
CC   -!- FUNCTION: AMP deaminase plays a critical role in energy
CC       metabolism.
CC   -!- CATALYTIC ACTIVITY: AMP + H(2)O = IMP + NH(3).
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via salvage pathway;
CC       IMP from AMP: step 1/1.
CC   -!- SUBUNIT: Homotetramer.
CC   -!- INTERACTION:
CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-1223554, EBI-352572;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1B;
CC         IsoId=Q01432-1; Sequence=Displayed;
CC       Name=1A;
CC         IsoId=Q01432-2; Sequence=VSP_001275, VSP_001277;
CC       Name=1C;
CC         IsoId=Q01432-3; Sequence=VSP_001276, VSP_001278;
CC       Name=2;
CC         IsoId=Q01432-4; Sequence=VSP_001275;
CC       Name=3;
CC         IsoId=Q01432-5; Sequence=VSP_001276;
CC       Name=4;
CC         IsoId=Q01432-6; Sequence=VSP_044230;
CC   -!- DISEASE: Adenosine monophosphate deaminase deficiency erythrocyte
CC       type (AMPDDE) [MIM:612874]: A metabolic disorder due to lack of
CC       activity of the erythrocyte isoform of AMP deaminase. It is a
CC       clinically asymptomatic condition characterized by a 50% increase
CC       in steady-state levels of ATP in affected cells. Individuals with
CC       complete deficiency of erythrocyte AMP deaminase are healthy and
CC       have no hematologic disorders. {ECO:0000269|PubMed:11139257,
CC       ECO:0000269|PubMed:7881427, ECO:0000269|PubMed:8004104,
CC       ECO:0000269|PubMed:9598089}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the adenosine and AMP deaminases family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D12775; BAA02240.1; -; mRNA.
DR   EMBL; M84720; AAA58365.1; -; mRNA.
DR   EMBL; M84721; AAA58366.1; -; mRNA.
DR   EMBL; M84722; AAA58367.1; -; mRNA.
DR   EMBL; U29926; AAB60410.1; -; Genomic_DNA.
DR   EMBL; U29929; AAB60410.1; JOINED; Genomic_DNA.
DR   EMBL; U29907; AAB60410.1; JOINED; Genomic_DNA.
DR   EMBL; U29909; AAB60410.1; JOINED; Genomic_DNA.
DR   EMBL; U29910; AAB60410.1; JOINED; Genomic_DNA.
DR   EMBL; U29911; AAB60410.1; JOINED; Genomic_DNA.
DR   EMBL; U29916; AAB60410.1; JOINED; Genomic_DNA.
DR   EMBL; U29917; AAB60410.1; JOINED; Genomic_DNA.
DR   EMBL; U29918; AAB60410.1; JOINED; Genomic_DNA.
DR   EMBL; U29922; AAB60410.1; JOINED; Genomic_DNA.
DR   EMBL; U29924; AAB60410.1; JOINED; Genomic_DNA.
DR   EMBL; U29925; AAB60410.1; JOINED; Genomic_DNA.
DR   EMBL; U29926; AAB60408.1; -; Genomic_DNA.
DR   EMBL; U29912; AAB60408.1; JOINED; Genomic_DNA.
DR   EMBL; U29929; AAB60408.1; JOINED; Genomic_DNA.
DR   EMBL; U29907; AAB60408.1; JOINED; Genomic_DNA.
DR   EMBL; U29909; AAB60408.1; JOINED; Genomic_DNA.
DR   EMBL; U29910; AAB60408.1; JOINED; Genomic_DNA.
DR   EMBL; U29911; AAB60408.1; JOINED; Genomic_DNA.
DR   EMBL; U29916; AAB60408.1; JOINED; Genomic_DNA.
DR   EMBL; U29917; AAB60408.1; JOINED; Genomic_DNA.
DR   EMBL; U29918; AAB60408.1; JOINED; Genomic_DNA.
DR   EMBL; U29922; AAB60408.1; JOINED; Genomic_DNA.
DR   EMBL; U29924; AAB60408.1; JOINED; Genomic_DNA.
DR   EMBL; U29925; AAB60408.1; JOINED; Genomic_DNA.
DR   EMBL; U29926; AAB60409.1; -; Genomic_DNA.
DR   EMBL; U29927; AAB60409.1; JOINED; Genomic_DNA.
DR   EMBL; U29929; AAB60409.1; JOINED; Genomic_DNA.
DR   EMBL; U29907; AAB60409.1; JOINED; Genomic_DNA.
DR   EMBL; U29909; AAB60409.1; JOINED; Genomic_DNA.
DR   EMBL; U29910; AAB60409.1; JOINED; Genomic_DNA.
DR   EMBL; U29911; AAB60409.1; JOINED; Genomic_DNA.
DR   EMBL; U29916; AAB60409.1; JOINED; Genomic_DNA.
DR   EMBL; U29917; AAB60409.1; JOINED; Genomic_DNA.
DR   EMBL; U29918; AAB60409.1; JOINED; Genomic_DNA.
DR   EMBL; U29922; AAB60409.1; JOINED; Genomic_DNA.
DR   EMBL; U29924; AAB60409.1; JOINED; Genomic_DNA.
DR   EMBL; U29925; AAB60409.1; JOINED; Genomic_DNA.
DR   EMBL; D31646; BAA06505.1; -; Genomic_DNA.
DR   EMBL; AK289998; BAF82687.1; -; mRNA.
DR   EMBL; AK295046; BAH11958.1; -; mRNA.
DR   EMBL; AK301507; BAH13499.1; -; mRNA.
DR   EMBL; AK302970; BAH13863.1; -; mRNA.
DR   EMBL; AC084117; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471064; EAW68567.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68568.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68569.1; -; Genomic_DNA.
DR   EMBL; BC126118; AAI26119.1; -; mRNA.
DR   CCDS; CCDS41617.1; -. [Q01432-1]
DR   CCDS; CCDS44537.1; -. [Q01432-5]
DR   CCDS; CCDS53601.1; -. [Q01432-6]
DR   CCDS; CCDS7802.1; -. [Q01432-4]
DR   PIR; S68146; S68146.
DR   PIR; S68147; S68147.
DR   RefSeq; NP_000471.1; NM_000480.2. [Q01432-4]
DR   RefSeq; NP_001020560.1; NM_001025389.1. [Q01432-1]
DR   RefSeq; NP_001020561.1; NM_001025390.1. [Q01432-5]
DR   RefSeq; NP_001165901.1; NM_001172430.1. [Q01432-1]
DR   RefSeq; NP_001165902.1; NM_001172431.1. [Q01432-6]
DR   UniGene; Hs.501890; -.
DR   ProteinModelPortal; Q01432; -.
DR   SMR; Q01432; -.
DR   BioGrid; 106769; 2.
DR   IntAct; Q01432; 6.
DR   STRING; 9606.ENSP00000379802; -.
DR   BindingDB; Q01432; -.
DR   ChEMBL; CHEMBL2912; -.
DR   iPTMnet; Q01432; -.
DR   PhosphoSitePlus; Q01432; -.
DR   BioMuta; AMPD3; -.
DR   DMDM; 399033; -.
DR   EPD; Q01432; -.
DR   MaxQB; Q01432; -.
DR   PaxDb; Q01432; -.
DR   PeptideAtlas; Q01432; -.
DR   PRIDE; Q01432; -.
DR   DNASU; 272; -.
DR   Ensembl; ENST00000396553; ENSP00000379801; ENSG00000133805. [Q01432-1]
DR   Ensembl; ENST00000396554; ENSP00000379802; ENSG00000133805. [Q01432-4]
DR   Ensembl; ENST00000444303; ENSP00000396000; ENSG00000133805. [Q01432-6]
DR   Ensembl; ENST00000528723; ENSP00000436987; ENSG00000133805. [Q01432-5]
DR   Ensembl; ENST00000529507; ENSP00000431648; ENSG00000133805. [Q01432-1]
DR   GeneID; 272; -.
DR   KEGG; hsa:272; -.
DR   UCSC; uc001min.2; human. [Q01432-1]
DR   CTD; 272; -.
DR   DisGeNET; 272; -.
DR   GeneCards; AMPD3; -.
DR   HGNC; HGNC:470; AMPD3.
DR   HPA; HPA038662; -.
DR   HPA; HPA047408; -.
DR   MalaCards; AMPD3; -.
DR   MIM; 102772; gene.
DR   MIM; 612874; phenotype.
DR   neXtProt; NX_Q01432; -.
DR   OpenTargets; ENSG00000133805; -.
DR   Orphanet; 45; Adenosine monophosphate deaminase deficiency.
DR   PharmGKB; PA24778; -.
DR   eggNOG; KOG1096; Eukaryota.
DR   eggNOG; COG1816; LUCA.
DR   GeneTree; ENSGT00390000008190; -.
DR   HOGENOM; HOG000092200; -.
DR   HOVERGEN; HBG050494; -.
DR   InParanoid; Q01432; -.
DR   KO; K01490; -.
DR   OMA; MMELNEP; -.
DR   OrthoDB; EOG091G01OU; -.
DR   PhylomeDB; Q01432; -.
DR   TreeFam; TF300439; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-74217; Purine salvage.
DR   SABIO-RK; Q01432; -.
DR   UniPathway; UPA00591; UER00663.
DR   ChiTaRS; AMPD3; human.
DR   GeneWiki; AMPD3; -.
DR   GenomeRNAi; 272; -.
DR   PRO; PR:Q01432; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000133805; -.
DR   CleanEx; HS_AMPD3; -.
DR   ExpressionAtlas; Q01432; baseline and differential.
DR   Genevisible; Q01432; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0003876; F:AMP deaminase activity; EXP:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046031; P:ADP metabolic process; IEA:Ensembl.
DR   GO; GO:0006196; P:AMP catabolic process; TAS:ProtInc.
DR   GO; GO:0046034; P:ATP metabolic process; IEA:Ensembl.
DR   GO; GO:0097009; P:energy homeostasis; IEA:Ensembl.
DR   GO; GO:0034101; P:erythrocyte homeostasis; IEA:Ensembl.
DR   GO; GO:0046039; P:GTP metabolic process; IEA:Ensembl.
DR   GO; GO:0032264; P:IMP salvage; IEA:UniProtKB-UniPathway.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0043101; P:purine-containing compound salvage; TAS:Reactome.
DR   CDD; cd01319; AMPD; 1.
DR   InterPro; IPR006650; A/AMP_deam_AS.
DR   InterPro; IPR001365; A/AMP_deaminase_dom.
DR   InterPro; IPR006329; AMPD.
DR   InterPro; IPR029771; AMPD3.
DR   InterPro; IPR032466; Metal_Hydrolase.
DR   PANTHER; PTHR11359; PTHR11359; 1.
DR   PANTHER; PTHR11359:SF12; PTHR11359:SF12; 1.
DR   Pfam; PF00962; A_deaminase; 1.
DR   PIRSF; PIRSF001251; AMP_deaminase_met; 1.
DR   SFLD; SFLDF00063; AMP_deaminase; 1.
DR   SUPFAM; SSF51556; SSF51556; 1.
DR   TIGRFAMs; TIGR01429; AMP_deaminase; 1.
DR   PROSITE; PS00485; A_DEAMINASE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation; Hydrolase;
KW   Metal-binding; Nucleotide metabolism; Phosphoprotein; Polymorphism;
KW   Reference proteome; Zinc.
FT   CHAIN         1    767       AMP deaminase 3.
FT                                /FTId=PRO_0000194410.
FT   REGION      388    393       Substrate binding. {ECO:0000250}.
FT   REGION      664    667       Substrate binding. {ECO:0000250}.
FT   ACT_SITE    608    608       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10104}.
FT   METAL       317    317       Zinc; catalytic. {ECO:0000250}.
FT   METAL       319    319       Zinc; catalytic. {ECO:0000250}.
FT   METAL       586    586       Zinc; catalytic. {ECO:0000250}.
FT   METAL       663    663       Zinc; catalytic. {ECO:0000250}.
FT   BINDING     319    319       Substrate. {ECO:0000250}.
FT   BINDING     589    589       Substrate. {ECO:0000250}.
FT   MOD_RES      85     85       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     107    107       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   VAR_SEQ       1    159       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044230.
FT   VAR_SEQ       1      1       M -> MALSSEPAEM (in isoform 1A and
FT                                isoform 2). {ECO:0000303|PubMed:1400401,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_001275.
FT   VAR_SEQ       1      1       M -> MEPGSAEM (in isoform 1C and isoform
FT                                3). {ECO:0000303|PubMed:1400401,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_001276.
FT   VAR_SEQ     208    767       Missing (in isoform 1A).
FT                                {ECO:0000303|PubMed:1400401}.
FT                                /FTId=VSP_001277.
FT   VAR_SEQ     652    767       Missing (in isoform 1C).
FT                                {ECO:0000303|PubMed:1400401}.
FT                                /FTId=VSP_001278.
FT   VARIANT     185    185       R -> W (in dbSNP:rs11042836).
FT                                /FTId=VAR_033499.
FT   VARIANT     310    310       N -> K (in AMPDDE).
FT                                {ECO:0000269|PubMed:7881427}.
FT                                /FTId=VAR_042606.
FT   VARIANT     311    311       V -> L (in AMPDDE; dbSNP:rs117706710).
FT                                {ECO:0000269|PubMed:9598089}.
FT                                /FTId=VAR_042607.
FT   VARIANT     320    320       A -> V (in AMPDDE; dbSNP:rs147542803).
FT                                {ECO:0000269|PubMed:7881427}.
FT                                /FTId=VAR_042608.
FT   VARIANT     324    324       M -> T (in AMPDDE; dbSNP:rs750004231).
FT                                {ECO:0000269|PubMed:7881427}.
FT                                /FTId=VAR_042609.
FT   VARIANT     331    331       R -> C (in AMPDDE; dbSNP:rs758038726).
FT                                {ECO:0000269|PubMed:7881427}.
FT                                /FTId=VAR_042610.
FT   VARIANT     402    402       R -> C (in AMPDDE; dbSNP:rs766280048).
FT                                {ECO:0000269|PubMed:7881427}.
FT                                /FTId=VAR_042611.
FT   VARIANT     450    450       W -> R (in AMPDDE).
FT                                {ECO:0000269|PubMed:11139257,
FT                                ECO:0000269|PubMed:7881427}.
FT                                /FTId=VAR_042612.
FT   VARIANT     455    455       Y -> H (in dbSNP:rs36003153).
FT                                /FTId=VAR_042613.
FT   VARIANT     573    573       R -> C (in AMPDDE; enzyme inactive;
FT                                dbSNP:rs3741040).
FT                                {ECO:0000269|PubMed:8004104}.
FT                                /FTId=VAR_009881.
FT   VARIANT     585    585       P -> L (in AMPDDE; dbSNP:rs748852415).
FT                                {ECO:0000269|PubMed:7881427}.
FT                                /FTId=VAR_042614.
FT   VARIANT     712    712       Q -> P (in AMPDDE).
FT                                {ECO:0000269|PubMed:11139257}.
FT                                /FTId=VAR_042615.
SQ   SEQUENCE   767 AA;  88812 MW;  2E0A2C629003B98C CRC64;
     MPRQFPKLNI SEVDEQVRLL AEKVFAKVLR EEDSKDALSL FTVPEDCPIG QKEAKERELQ
     KELAEQKSVE TAKRKKSFKM IRSQSLSLQM PPQQDWKGPP AASPAMSPTT PVVTGATSLP
     TPAPYAMPEF QRVTISGDYC AGITLEDYEQ AAKSLAKALM IREKYARLAY HRFPRITSQY
     LGHPRADTAP PEEGLPDFHP PPLPQEDPYC LDDAPPNLDY LVHMQGGILF VYDNKKMLEH
     QEPHSLPYPD LETYTVDMSH ILALITDGPT KTYCHRRLNF LESKFSLHEM LNEMSEFKEL
     KSNPHRDFYN VRKVDTHIHA AACMNQKHLL RFIKHTYQTE PDRTVAEKRG RKITLRQVFD
     GLHMDPYDLT VDSLDVHAGR QTFHRFDKFN SKYNPVGASE LRDLYLKTEN YLGGEYFARM
     VKEVARELEE SKYQYSEPRL SIYGRSPEEW PNLAYWFIQH KVYSPNMRWI IQVPRIYDIF
     RSKKLLPNFG KMLENIFLPL FKATINPQDH RELHLFLKYV TGFDSVDDES KHSDHMFSDK
     SPNPDVWTSE QNPPYSYYLY YMYANIMVLN NLRRERGLST FLFRPHCGEA GSITHLVSAF
     LTADNISHGL LLKKSPVLQY LYYLAQIPIA MSPLSNNSLF LEYSKNPLRE FLHKGLHVSL
     STDDPMQFHY TKEALMEEYA IAAQVWKLST CDLCEIARNS VLQSGLSHQE KQKFLGQNYY
     KEGPEGNDIR KTNVAQIRMA FRYETLCNEL SFLSDAMKSE EITALTN
//
